Endo Makes a Play in the Generics Market

November 2010
Pharmaceutical Representative;Nov2010, Vol. 40 Issue 11, p7
The article offers updates on several pharmaceutical companies in the U.S. It includes Endo Pharmaceuticals Inc., Pfizer Inc. and Aegerion Pharmaceuticals Inc. It notes that Endo Pharmaceuticals Inc. has acquired the privately held company Quality Pharmaceuticals Inc. for about 1.2 billion dollars in cash.


Related Articles

  • MANUFACTURERS INDEX.  // Monthly Prescribing Reference;Jan2017, Vol. 33 Issue 1, p276 

    No abstract available.

  • General News.  // PharmaWatch: CNS;Feb2009, Vol. 8 Issue 2, p19 

    The article offers news briefs related to pharmaceutical industry. The Endo Pharmaceuticals Inc. and the Indevus Pharmaceuticals Inc. have merged for $370 million Indevus shares. The Copernicus Therapeutics Inc. and the University of Kentucky declared a collaboration to create a DNA nanoparticle...

  • The Industry.  // Pharmaceutical Representative;Mar2009, Vol. 39 Issue 3, p10 

    The article offers news briefs related to pharmaceutical industry. Endo Pharmaceuticals Inc. has bought outstanding shares of Indevus Pharmaceuticals Inc. for almost $370 million, in addition to $267 million in potential regulatory. GlaxoSmithKline is acquiring UCB's products and commercial...

  • Pfizer buys Pharmacia for $60bn. McKenna, Claire // BMJ: British Medical Journal (International Edition);7/20/2002, Vol. 325 Issue 7356, p123 

    Reports that Pfizer has purchased Pharmacia, a rival pharmaceutical company. Position of Pfizer as the world's leading pharmaceutical company; Competition between Pfizer and GlaxoSmithKline; Products which will be gained by Pfizer through the merger, including the arthritis drug Celebrex.

  • Incretin mimetics vie for slice of type 2 diabetes market. Shaffer, Catherine // Nature Biotechnology;Mar2007, Vol. 25 Issue 3, p263 

    The article reports that New York-based Pfizer's acquisition of BioRexis Pharmaceutical has made it one of the growing number of companies looking for a share of the worldwide market in diabetes. The increase of the interest of pharmaceutical companies in novel targets for injectable...

  • Pfizer acquires UK drug delivery technology firm.  // PharmaWatch: Biotechnology;November 2004, Vol. 3 Issue 11, p19 

    Reports that industry leading pharmaceuticals group Pfizer is set to pay $125 million to fully acquire Meridica Ltd., a drug delivery technology company based in Cambridge, England. Expected completion of the transaction in the fourth quarter of 2004; Background on Meridica.

  • OTC: REPORTERS Notebook.  // Drug Store News;1/15/2007, Vol. 29 Issue 1, p49 

    The article reports on the acquisition of Pfizer Inc. by Johnson & Johnson Inc. (Johnson & J) in December 2006 in the U.S. With the effort, Johnson & J Consumer Group portfolio will feature products including Listerine oral care products, Nicorette line of smoking cessation treatments and...

  • Reverse Commute. Messina, Judith // Crain's New York Business;6/23/2003, Vol. 19 Issue 25, p15 

    The news that Pfizer Inc. planned to shift 1,000 jobs to Manhattan, New York from New Jersey, Missouri, Michigan and California took many by surprise. Since Sept. 11, 2001 almost all the major relocation traffic has been headed in the opposite direction. However, the pharmaceutical giant, which...

  • Pfizer to Buy CSL Animal Health.  // Chemical Market Reporter;12/22/2003, Vol. 264 Issue 22, p3 

    Reports on the acquisition of CSL Animal Health, a division of the Melbourne-based biopharmaceutical firm, CSL Ltd. by Pfizer Animal Health. Terms and details of the acquisition; Acquisition of access to CSL line of livestock and companion animal vaccines, a sales force and manufacturing...


Read the Article


Sign out of this library

Other Topics